SHEPHERD WEALTH MANAGEMENT Ltd LIABILITY Co Acquires New Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SHEPHERD WEALTH MANAGEMENT Ltd LIABILITY Co acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to its most recent filing with the SEC. The fund acquired 543 shares of the medical equipment provider’s stock, valued at approximately $283,000.

Several other institutional investors have also recently modified their holdings of the stock. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $26,000. BankPlus Trust Department acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $28,000. Kohmann Bosshard Financial Services LLC acquired a new stake in Intuitive Surgical during the 4th quarter valued at approximately $31,000. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical in the third quarter valued at $33,000. Finally, Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $36,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 13,309 shares of company stock valued at $7,611,004 over the last ninety days. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $493.72 on Wednesday. The company has a fifty day moving average price of $569.91 and a two-hundred day moving average price of $531.84. The stock has a market cap of $175.85 billion, a P/E ratio of 77.02, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on ISRG. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Evercore ISI increased their price target on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Raymond James boosted their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Bernstein Bank raised their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Finally, Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.